Pacific Shuanglin Bio-pharmacy Balance Sheet Health
Financial Health criteria checks 6/6
Pacific Shuanglin Bio-pharmacy has a total shareholder equity of CN¥7.5B and total debt of CN¥528.2M, which brings its debt-to-equity ratio to 7%. Its total assets and total liabilities are CN¥8.7B and CN¥1.2B respectively. Pacific Shuanglin Bio-pharmacy's EBIT is CN¥713.7M making its interest coverage ratio -9.8. It has cash and short-term investments of CN¥1.8B.
Key information
7.0%
Debt to equity ratio
CN¥528.15m
Debt
Interest coverage ratio | -9.8x |
Cash | CN¥1.76b |
Equity | CN¥7.54b |
Total liabilities | CN¥1.17b |
Total assets | CN¥8.72b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 000403's short term assets (CN¥3.4B) exceed its short term liabilities (CN¥859.1M).
Long Term Liabilities: 000403's short term assets (CN¥3.4B) exceed its long term liabilities (CN¥314.2M).
Debt to Equity History and Analysis
Debt Level: 000403 has more cash than its total debt.
Reducing Debt: 000403's debt to equity ratio has reduced from 28% to 7% over the past 5 years.
Debt Coverage: 000403's debt is well covered by operating cash flow (98.6%).
Interest Coverage: 000403 earns more interest than it pays, so coverage of interest payments is not a concern.